Cargando…

The Anti-Tumor Activity of the NEDD8 Inhibitor Pevonedistat in Neuroblastoma

Pevonedistat is a neddylation inhibitor that blocks proteasomal degradation of cullin–RING ligase (CRL) proteins involved in the degradation of short-lived regulatory proteins, including those involved with cell-cycle regulation. We determined the sensitivity and mechanism of action of pevonedistat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Foster, Jennifer H., Barbieri, Eveline, Zhang, Linna, Scorsone, Kathleen A., Moreno-Smith, Myrthala, Zage, Peter, Horton, Terzah M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8234433/ https://www.ncbi.nlm.nih.gov/pubmed/34207315 http://dx.doi.org/10.3390/ijms22126565

Ejemplares similares

Synergistic anti-AML effects of the LSD1 inhibitor T-3775440 and the NEDD8-activating enzyme inhibitor pevonedistat via transdifferentiation and DNA rereplication
por: Ishikawa, Y, et al.
Publicado: (2017)

Binimetinib inhibits MEK and is effective against neuroblastoma tumor cells with low NF1 expression
por: Woodfield, Sarah E., et al.
Publicado: (2016)

Radiosensitization by the investigational NEDD8-activating enzyme inhibitor MLN4924 (pevonedistat) in hormone-resistant prostate cancer cells
por: Wang, Xiaofang, et al.
Publicado: (2016)

Pevonedistat, a Nedd8-activating enzyme inhibitor, sensitizes neoplastic B-cells to death receptor-mediated apoptosis
por: Paiva, Cody, et al.
Publicado: (2017)

Correction: Synergistic anti-AML effects of the LSD1 inhibitor T-3775440 and the NEDD8-activating enzyme inhibitor pevonedistat via transdifferentiation and DNA rereplication
por: Ishikawa, Y., et al.
Publicado: (2019)

Pevonedistat, a Nedd8-activating enzyme inhibitor, in combination with ibrutinib in patients with relapsed/refractory B-cell non-Hodgkin lymphoma
por: Torka, Pallawi, et al.
Publicado: (2023)

A phase I study of the investigational NEDD8-activating enzyme inhibitor pevonedistat (TAK-924/MLN4924) in patients with metastatic melanoma
por: Bhatia, Shailender, et al.
Publicado: (2016)

Expanded safety analysis of pevonedistat, a first-in-class NEDD8-activating enzyme inhibitor, in patients with acute myeloid leukemia and myelodysplastic syndromes
por: Swords, R T, et al.
Publicado: (2017)

Phase 1 study to evaluate the effects of rifampin on pharmacokinetics of pevonedistat, a NEDD8-activating enzyme inhibitor in patients with advanced solid tumors
por: Zhou, Xiaofei, et al.
Publicado: (2022)

Phase Ib study of pevonedistat, a NEDD8-activating enzyme inhibitor, in combination with docetaxel, carboplatin and paclitaxel, or gemcitabine, in patients with advanced solid tumors
por: Lockhart, A Craig, et al.
Publicado: (2018)

The use of the NEDD8 inhibitor MLN4924 (Pevonedistat) in a cyclotherapy approach to protect wild-type p53 cells from MLN4924 induced toxicity
por: Malhab, Lara J. Bou, et al.
Publicado: (2016)

Phase I study assessing the mass balance, pharmacokinetics, and excretion of [(14)C]-pevonedistat, a NEDD8-activating enzyme inhibitor in patients with advanced solid tumors
por: Zhou, Xiaofei, et al.
Publicado: (2020)

Pevonedistat, a NEDD8‐activating enzyme inhibitor, induces apoptosis and augments efficacy of chemotherapy and small molecule inhibitors in pre‐clinical models of diffuse large B‐cell lymphoma
por: Torka, Pallawi, et al.
Publicado: (2020)

The Nedd8‐activating enzyme inhibitor MLN4924 (TAK‐924/Pevonedistat) induces apoptosis via c‐Myc‐Noxa axis in head and neck squamous cell carcinoma
por: Zhang, Wenjuan, et al.
Publicado: (2018)

Nifurtimox Is Effective Against Neural Tumor Cells and Is Synergistic with Buthionine Sulfoximine
por: Du, Michael, et al.
Publicado: (2016)

Dual targeting of MDM2 and BCL2 as a therapeutic strategy in neuroblastoma
por: Van Goethem, Alan, et al.
Publicado: (2017)

The synergy of BET inhibitors with aurora A kinase inhibitors in MYCN-amplified neuroblastoma is heightened with functional TP53
por: Yi, Joanna S., et al.
Publicado: (2021)

ABCG2 Overexpression Contributes to Pevonedistat Resistance
por: Kathawala, Rishil J., et al.
Publicado: (2020)

Novel Therapies for Relapsed and Refractory Neuroblastoma
por: Zage, Peter E.
Publicado: (2018)

The NAE inhibitor pevonedistat (MLN4924) synergizes with TNF-α to activate apoptosis
por: Wolenski, F S, et al.
Publicado: (2015)

MYCN-driven fatty acid uptake is a metabolic vulnerability in neuroblastoma
por: Tao, Ling, et al.
Publicado: (2022)

Longitudinal evaluation of serum microRNAs as biomarkers for neuroblastoma burden and therapeutic p53 reactivation
por: Van Goethem, Alan, et al.
Publicado: (2023)

Effect of CYP3A inhibitors on the pharmacokinetics of pevonedistat in patients with advanced solid tumours
por: Faessel, Hélène, et al.
Publicado: (2019)

A Metal-Based Inhibitor of NEDD8-Activating Enzyme
por: Zhong, Hai-Jing, et al.
Publicado: (2012)

Restoration of the molecular clock is tumor suppressive in neuroblastoma
por: Moreno-Smith, Myrthala, et al.
Publicado: (2021)

Stress, specificity and the NEDD8 proteome
por: Lane, David P.
Publicado: (2012)

The NEDD8 modification pathway in plants
por: Mergner, Julia, et al.
Publicado: (2014)

Pevonedistat Suppresses Pancreatic Cancer Growth via Inactivation of the Neddylation Pathway
por: Xu, Junfeng, et al.
Publicado: (2022)

The multikinase inhibitor RXDX-105 is effective against neuroblastoma in vitro and in vivo
por: Flynn, Sean M., et al.
Publicado: (2019)

Pevonedistat (MLN4924): mechanism of cell death induction and therapeutic potential in colorectal cancer
por: Ferris, Jennifer, et al.
Publicado: (2020)

Nedd8 processing enzymes in Schizosaccharomyces pombe
por: O’Donoghue, Jean E, et al.
Publicado: (2013)

Structural and functional consequences of NEDD8 phosphorylation
por: Stuber, Katrin, et al.
Publicado: (2021)

Discovery of Nedd4 auto-ubiquitination inhibitors
por: Yong, Darren, et al.
Publicado: (2023)

Allele-specific expression reveals genes with recurrent cis-regulatory alterations in high-risk neuroblastoma
por: Sen, Arko, et al.
Publicado: (2022)

Old and New Concepts in Ubiquitin and NEDD8 Recognition
por: Santonico, Elena
Publicado: (2020)

Nedd8 hydrolysis by UCH proteases in Plasmodium parasites
por: Karpiyevich, Maryia, et al.
Publicado: (2019)

The Potential Functional Roles of NME1 Histidine Kinase Activity in Neuroblastoma Pathogenesis
por: Adam, Kevin, et al.
Publicado: (2020)

The NEDD8-activating enzyme inhibitor MLN4924 reduces ischemic brain injury in mice
por: Yu, Huilin, et al.
Publicado: (2022)

The Molecular Determinants of NEDD8 Specific Recognition by Human SENP8
por: Shin, Yung-Cheng, et al.
Publicado: (2011)

The development of pevonedistat in myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML): hope or hype?
por: Snow, Anson, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_qddpfo32vrs24s8vkj9g6dct28